Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Smith NathanChief Financial Officer | Tax withholding | F | $79K 3,859 sh | Feb 4, 2026 |
| 16 | Clark Kyra ESenior Vice President | Tax withholding | F | $63K 1,045 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Kleczynski Robert ASVP, Controller & Tax | Tax withholding | F | $165K 3,768 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $133K 576 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Kleczynski Robert ASVP, Controller & Tax | Disposition to issuer | D | $218K 4,963 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $140K 600 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 15 | Dawsey James MDirector | Grant or award | A | $27K 818 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 15 | France NatashaSEE REMARKS | Tax withholding | F | $16K 3,100 sh | Feb 4, 2026 traded Feb 1, 2026 |
| 15 | Munari Alvise J.Chief Product Officer | Tax withholding | F | $274K 438 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 15 | Frew JamesSEE REMARKS | Option exercise | M | — 50.6K sh | Feb 4, 2026 traded Feb 1, 2026 |
| 15 | Zalenko Neal F.Director | Small acquisition | L | $6,350 588 sh | Feb 4, 2026 traded Jan 27, 2026 |
| 15 | White Daniel JamesDirector | Grant or award | A | $27K 818 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 15 | Furbee DanielDirector, SEE REMARKS | Option exercise | M | — 51.6K sh | Feb 4, 2026 traded Feb 1, 2026 |
| 15 | Jahnel DarrinDirector | Grant or award | A | $2,238 69 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 13 | Lee CindyChief Financial Officer | Tax withholding | F | — 1,246 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 13 | Clark Kyra ESenior Vice President | Grant or award | A | — 1,275 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Cooke Malcolm G.VP, Chief Info Tech Officer | Tax withholding | F | $37K 6,658 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Lee CindyChief Financial Officer | Option exercise | M | — 2,749 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Hill Donna K.VP, Human Resources | Tax withholding | F | $33K 6,037 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Jones Jeanne MEVP, CFO, Audit & Risk | Option exercise | M | — 7,031 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Jones Jeanne MEVP, CFO, Audit & Risk | Option exercise | M | — 5,197 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Carr DouglasSVP Finance & Operations | Grant or award | A | — 110.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Novack Jeffrey AdamSecretary and General Counsel | Grant or award | A | — 33.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Robinson-Gay DonaldSenior Vice President | Grant or award | A | — 1,275 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Clark Kyra ESenior Vice President | Grant or award | A | — 1,802 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 13 | Wampler Kira SchererDirector | Open-market sale · 10b5-1 plan | SELL | $75K 2,000 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Russotti GregorySee Remarks | Grant or award | A | — 135.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Cota GermaineChief Accting. Off. & VP, Fin. | Grant or award | A | — 3,116 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Schafer JoshuaCCO | Open-market sale · 10b5-1 plan | SELL | $97K 10.5K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 13 | Lee CindyChief Financial Officer | Option exercise | M | — 3,090 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 13 | Meng JessicaChief Commercial Officer | Grant or award | A | — 11.6K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $18K 80 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Sharma ManishChief Strategy & Services Ofcr | Open-market sale · 10b5-1 plan | SELL | $25K 98 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 13 | Parker Stuart B.Director | Grant or award | A | — 1,263 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $3,744 16 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Conway Kevin JohnChief Financial Officer | Option exercise | M | — 235 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Quigley AdamChief Financial Officer | Grant or award | A | $18K 190 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Lee CindyChief Financial Officer | Tax withholding | F | — 1,108 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Gutman CarrieSenior Vice President | Tax withholding | F | $20K 321 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Smith NathanChief Financial Officer | Grant or award | A | — 7,875 sh | Feb 4, 2026 traded Feb 2, 2026 |